Discovery and validation of acetyl-L-carnitine in serum for diagnosis of major depressive disorder and remission status through metabolomic approach.

MLA

Lee, Seungyeon, et al. “Discovery and Validation of Acetyl-L-Carnitine in Serum for Diagnosis of Major Depressive Disorder and Remission Status through Metabolomic Approach.” Frontiers in Psychiatry, vol. 13, Nov. 2022, p. 1002828. EBSCOhost, https://doi.org/10.3389/fpsyt.2022.1002828.

APA

Lee, S., Mun, S., Lee, Y.-R., Choi, H., Joo, E.-J., Kang, H.-G., & Lee, J. (2022). Discovery and validation of acetyl-L-carnitine in serum for diagnosis of major depressive disorder and remission status through metabolomic approach. Frontiers in Psychiatry, 13, 1002828. https://doi.org/10.3389/fpsyt.2022.1002828

Chicago

Lee, Seungyeon, Sora Mun, You-Rim Lee, Hyebin Choi, Eun-Jeong Joo, Hee-Gyoo Kang, and Jiyeong Lee. 2022. “Discovery and Validation of Acetyl-L-Carnitine in Serum for Diagnosis of Major Depressive Disorder and Remission Status through Metabolomic Approach.” Frontiers in Psychiatry 13 (November): 1002828. doi:10.3389/fpsyt.2022.1002828.